IN2012DN04918A - - Google Patents

Download PDF

Info

Publication number
IN2012DN04918A
IN2012DN04918A IN4918DEN2012A IN2012DN04918A IN 2012DN04918 A IN2012DN04918 A IN 2012DN04918A IN 4918DEN2012 A IN4918DEN2012 A IN 4918DEN2012A IN 2012DN04918 A IN2012DN04918 A IN 2012DN04918A
Authority
IN
India
Prior art keywords
skin
nucleic acid
polypeptides
various
exfoliation
Prior art date
Application number
Inventor
Hans Kristian Leren
Bernt Walther
Original Assignee
Aqua Bio Technology Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41572950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN04918(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aqua Bio Technology Asa filed Critical Aqua Bio Technology Asa
Publication of IN2012DN04918A publication Critical patent/IN2012DN04918A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6416—Metalloendopeptidases (3.4.24)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24066—Choriolysin L (3.4.24.66)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Detergent Compositions (AREA)

Abstract

The present invention relates to various polypeptides from fish hatching fluid, their encoding nucleic acid sequences, pharmaceutical compositions comprising said polypeptides and nucleic acid molecules and their use in various medical and cosmetic applications to the skin, particularly for moisturizing skin and/or for exfoliation of the horny layer of the skin for treating or preventing skin disorders or conditions in an animal.
IN4918DEN2012 2009-11-30 2010-11-30 IN2012DN04918A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0921001A GB0921001D0 (en) 2009-11-30 2009-11-30 Products and uses
PCT/EP2010/068509 WO2011064384A1 (en) 2009-11-30 2010-11-30 Hatching fluid enzymes and uses thereof

Publications (1)

Publication Number Publication Date
IN2012DN04918A true IN2012DN04918A (en) 2015-09-25

Family

ID=41572950

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4918DEN2012 IN2012DN04918A (en) 2009-11-30 2010-11-30

Country Status (17)

Country Link
US (3) US9133256B2 (en)
EP (1) EP2506825B2 (en)
JP (1) JP5913117B2 (en)
KR (1) KR101842521B1 (en)
CN (2) CN104436163B (en)
AU (2) AU2010323022B2 (en)
CA (1) CA2781834C (en)
CL (1) CL2012001380A1 (en)
ES (1) ES2741586T5 (en)
GB (1) GB0921001D0 (en)
IN (1) IN2012DN04918A (en)
MX (1) MX340231B (en)
NZ (2) NZ600499A (en)
PL (1) PL2506825T5 (en)
RU (1) RU2595399C2 (en)
WO (1) WO2011064384A1 (en)
ZA (1) ZA201204066B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201110777D0 (en) * 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
GB201110783D0 (en) * 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
US9169203B2 (en) * 2012-01-06 2015-10-27 Novus International, Inc. Sulfoxide-based surfactants
PL2691069T3 (en) * 2012-01-23 2017-03-31 Restorsea, Llc Cosmetic
CN105025906B (en) * 2012-12-21 2020-08-25 阿克生物科技公司 Cosmetic composition from fish hatching fluid
GB201223330D0 (en) * 2012-12-21 2013-02-06 Aqua Bio Technology Asa Products, methods and uses
KR101505294B1 (en) * 2013-06-19 2015-03-23 강릉원주대학교산학협력단 Compositions for reducing keloid or scar
CA2933367A1 (en) 2013-12-13 2015-06-18 Restorsea, Llc Exfoliative hair retention-promoting formulation
EP3142633A1 (en) 2014-05-16 2017-03-22 Restorsea, LLC Biphasic cosmetic
US10584306B2 (en) 2017-08-11 2020-03-10 Board Of Regents Of The University Of Oklahoma Surfactant microemulsions
US20220347273A1 (en) * 2019-07-05 2022-11-03 Regenics As Wound debridement systems
CN110592054B (en) * 2019-08-29 2021-02-12 中国科学院南海海洋研究所 Hippocampus japonicus hatching enzyme gene and coding protein and application thereof
KR20240100757A (en) * 2022-12-23 2024-07-02 순천향대학교 산학협력단 Composition for wound healing or acne treatment containing sturgeon mucus as an active ingredient

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3393559B2 (en) * 1993-10-15 2003-04-07 株式会社ノエビア Skin preparation
FR2743723B1 (en) 1996-01-18 1998-04-17 Texinfine Sa USE OF EXTRACT FROM PLANTS OF THE DICTYOTAL FAMILY FOR THE PREPARATION OF PREPARATIONS FOR REFORMING THE GLYCOSYL ELEMENTS OF THE EXTRACELLULAR MATRIX OF LIVING TISSUES
NO314594B1 (en) * 1997-12-11 2003-04-14 Aqua Bio Technology As Non-self-degrading endoprotease, method of preparation and applications thereof
WO1999062315A2 (en) 1998-05-27 1999-12-02 Lauras As Method for altering the activity of proteins of the pka signaling pathway
FR2792202B1 (en) 1999-04-19 2003-06-13 Pharmascience Lab LUPINE PEPTIDE EXTRACT AND PHARMACEUTICAL OR COSMETIC OR NUTRACEUTICAL COMPOSITION COMPRISING SUCH EXTRACT
JP4643800B2 (en) 2000-06-16 2011-03-02 エム・ディジャパン株式会社 Protease inhibitor
WO2002066624A2 (en) * 2001-02-20 2002-08-29 Lexicon Genetics Incorporated Novel human protease and polynucleotides encoding the same
US20050074865A1 (en) 2002-08-27 2005-04-07 Compound Therapeutics, Inc. Adzymes and uses thereof
GB0230006D0 (en) 2002-12-23 2003-01-29 Ares Trading Sa Proteins
US20040180025A1 (en) * 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
JP4834554B2 (en) * 2003-11-06 2011-12-14 ジェネンコー・インターナショナル・インク Expression of protease inhibitors and their mutants in filamentous fungi
ATE486087T1 (en) * 2003-11-06 2010-11-15 Danisco Us Inc FGF-5 BINDING AND SUPPORTED PEPTIDES
US8357365B2 (en) * 2005-02-14 2013-01-22 The Regents Of The University Of California Granulysin peptides and methods of use thereof
JP2008094726A (en) 2006-10-06 2008-04-24 Towa Koso Kk Composition for microbubble cleaning, method for microbubble cleaning and apparatus for microbubble cleaning

Also Published As

Publication number Publication date
EP2506825A1 (en) 2012-10-10
NZ600499A (en) 2014-09-26
KR101842521B1 (en) 2018-03-27
AU2015202010B2 (en) 2017-04-20
US9133256B2 (en) 2015-09-15
RU2012127298A (en) 2014-01-20
CN104436163A (en) 2015-03-25
EP2506825B1 (en) 2019-05-08
RU2595399C2 (en) 2016-08-27
CA2781834A1 (en) 2011-06-03
GB0921001D0 (en) 2010-01-13
PL2506825T3 (en) 2019-11-29
CN104436163B (en) 2017-08-11
AU2015202010A1 (en) 2015-05-14
ES2741586T5 (en) 2023-08-18
ES2741586T3 (en) 2020-02-11
CN102724954A (en) 2012-10-10
EP2506825B2 (en) 2023-05-31
AU2010323022B2 (en) 2015-05-14
CN102724954B (en) 2018-07-27
US20160053249A1 (en) 2016-02-25
WO2011064384A1 (en) 2011-06-03
US9950031B2 (en) 2018-04-24
PL2506825T5 (en) 2023-07-10
US20120309689A1 (en) 2012-12-06
MX2012006090A (en) 2012-09-07
JP5913117B2 (en) 2016-04-27
ZA201204066B (en) 2013-08-28
AU2010323022A1 (en) 2012-06-21
US9624483B2 (en) 2017-04-18
CA2781834C (en) 2019-02-12
CL2012001380A1 (en) 2012-11-30
BR112012012909A2 (en) 2017-04-18
US20170189478A1 (en) 2017-07-06
MX340231B (en) 2016-07-01
KR20120115291A (en) 2012-10-17
JP2013511971A (en) 2013-04-11
NZ627941A (en) 2015-01-30

Similar Documents

Publication Publication Date Title
IN2012DN04918A (en)
WO2009080306A8 (en) Anti-dandruff compositions containing peptides
CY1118813T1 (en) PHARMACEUTICAL COMPOSITIONS OF TRAMADOL AND COXYL-CYLINDERS
MX339201B (en) Sulphonamide compounds and methods of making and using same.
MX2014014902A (en) Compositions comprising apomorphine and organic acids and uses thereof.
IL215503A0 (en) Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions
PL2640352T3 (en) Collagen hydrolysate used to improve the health of human skin, hair and/or nails
WO2007136679A3 (en) Targeting vegf-b regulation of fatty acid transporters to modulate human diseases
IL214462A0 (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions
IL219239A (en) Peptides for use in the treatment and/or care of the skin, mucous membranes and/or hair and their use in cosmetic or pharmaceutical compositions
BR112014019431A8 (en) COMPARTMENTALIZED METHOD OF DELIVERY OF NUCLEIC ACID AND COMPOSITIONS AND USES THEREOF
BR112015014532A2 (en) fish hatching fluid cosmetic compositions
UA113609C2 (en) ANTIGENCY BINDING PROTEIN Binding HUMAN IL-23
WO2011044506A3 (en) Sulphone compounds for use in the treatment of obesity
MY180626A (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
BR112014019623A8 (en) CONDITIONING ADDITIVE COMPOSITION TO PROVIDE LONG-TERM AND IMMEDIATE BENEFITS TO KERATIN SUBSTRATES
EA201391119A1 (en) DELIVERY SYSTEMS OF NANOPARTICLES, THEIR RECEIVING AND APPLICATION
EP3747457A3 (en) Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseases
ATE500265T1 (en) SYNTHETIC MECP2 SEQUENCE FOR PROTEIN REPLACEMENT THERAPY
MX2009004243A (en) Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use.
EP2560633A4 (en) Intravenous omega-3 fatty acid compositions & method of use
EA200970154A1 (en) COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING N-ACETYLCISTINE
IT1405793B1 (en) MOLECULE OF MODIFIED HUMAN U1SNRNA, CODIFYING GENE FOR THE MOLECULE OF MODIFIED HUMAN U1SNRNA, VECTOR OF EXPRESSION INCLUDING THE GENE, AND THEIR USE IN GENE THERAPY
EP2306824A4 (en) Iontophoretic delivery of curcumin and curcumin analogs for the treatment of alzheimer's disease
WO2008107092A3 (en) Use of derivatives of 4-hydroxyphenoxy acetic acid